Abstract

Abstract In the past, several authors have proposed comparable sets of clinical features to differentiate acquired neurogenic stuttering (ANS) from developmental stuttering (DS). Further, people with ANS have been reported to show no changes in their dysfluencies during various fluency-enhancing conditions. Although these features have been criticized on their aptness and reliability in differentiating the two disorders (e.g., Lebrun, Bijleveld, & Rousseau, 1990 ), clinicians and researchers around the world continue to use them even today. In this context, we compile evidence from investigations employing fluency-enhancing conditions in people with ANS to highlight that this group shows extreme variability (including beneficial effects) under such conditions. Further, by combining the evidence from this review as well as that of Lebrun and colleagues', we propose that the clinical features that are used to differentiate ANS from DS are often unreliable. Additionally, we highlight on: (a) the heterogeneity in the manifestation of ANS, (b) recent attempts to draw similarity between ANS and DS, as well as (c) the surprising dearth of functional neuroimaging investigations in ANS that could pave potential ways to future investigations in this fluency disorder.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.